Reply: Premature ovarian insufficiency and the risk of breast cancer.
作者信息
Panay Nick, Vermeulen Nathalie, Anderson Richard A, Vincent Amanda J
机构信息
Queen Charlotte's and Chelsea Hospital, Imperial College London, London, UK.
ESHRE Central Office, Strombeek-Bever, Belgium.
出版信息
Hum Reprod Open. 2025 Apr 9;2025(2):hoaf018. doi: 10.1093/hropen/hoaf018. eCollection 2025.
Abstract
摘要
相似文献
1
Reply: Premature ovarian insufficiency and the risk of breast cancer.回复：卵巢早衰与乳腺癌风险
Hum Reprod Open. 2025 Apr 9;2025(2):hoaf018. doi: 10.1093/hropen/hoaf018. eCollection 2025.
2
Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study.非妇科癌症女性青少年和年轻成年幸存者的卵巢早衰：基于人群的队列研究。
Reprod Health. 2023 Jan 2;20(1):4. doi: 10.1186/s12978-022-01559-8.
3
Premature ovarian insufficiency and the risk of breast cancer: author reply.卵巢早衰与乳腺癌风险：作者回复
Climacteric. 2025 Jun;28(3):367-368. doi: 10.1080/13697137.2025.2480588. Epub 2025 Apr 4.
4
Premature ovarian insufficiency and the risk of breast cancer: author reply.卵巢早衰与乳腺癌风险：作者回复
Fertil Steril. 2025 Jun;123(6):1152-1153. doi: 10.1016/j.fertnstert.2025.03.019. Epub 2025 Mar 26.
5
Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation.癌症女童和年轻女性的生育力保存：基于人群的卵巢组织冷冻保存标准验证
Lancet Oncol. 2014 Sep;15(10):1129-36. doi: 10.1016/S1470-2045(14)70334-1. Epub 2014 Aug 14.
6
Factors influencing premature ovarian insufficiency: a systematic review and meta-analysis.影响卵巢早衰的因素：一项系统评价和荟萃分析
J Obstet Gynaecol. 2025 Dec;45(1):2469331. doi: 10.1080/01443615.2025.2469331. Epub 2025 Feb 27.
7
Birth weight and premature ovarian insufficiency: a systematic review and meta-analysis.出生体重与早发性卵巢功能不全：系统评价和荟萃分析。
J Ovarian Res. 2024 Apr 3;17(1):74. doi: 10.1186/s13048-024-01357-9.
8
Oligogenic basis of premature ovarian insufficiency: an observational study.早发性卵巢功能不全的寡基因基础：一项观察性研究。
J Ovarian Res. 2024 Feb 3;17(1):32. doi: 10.1186/s13048-024-01351-1.
9
Bone density changes in premature ovarian insufficiency patients who have had term pregnancies.有足月妊娠史的卵巢早衰患者的骨密度变化
Post Reprod Health. 2014 Dec;20(4):148-50. doi: 10.1177/2053369114547717. Epub 2014 Sep 11.
10
Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.血清雄激素谱在卵巢早衰女性中的表现：系统评价和荟萃分析。
Menopause. 2019 Jan;26(1):78-93. doi: 10.1097/GME.0000000000001161.
本文引用的文献
1
Premature ovarian insufficiency and the risk of breast cancer.卵巢早衰与乳腺癌风险
Hum Reprod Open. 2025 Apr 10;2025(2):hoaf017. doi: 10.1093/hropen/hoaf017. eCollection 2025.
2
Premature ovarian insufficiency and the risk of breast cancer.卵巢早衰与乳腺癌风险
Climacteric. 2025 Jun;28(3):365-366. doi: 10.1080/13697137.2025.2480581. Epub 2025 Apr 4.
3
Evidence-based guideline: premature ovarian insufficiency.循证指南：卵巢早衰
Hum Reprod Open. 2024 Dec 9;2024(4):hoae065. doi: 10.1093/hropen/hoae065. eCollection 2024.
4
Evidence-based guideline: Premature Ovarian Insufficiency.循证指南：卵巢早衰
Fertil Steril. 2025 Feb;123(2):221-236. doi: 10.1016/j.fertnstert.2024.11.007. Epub 2024 Dec 9.
5
Evidence-based guideline: premature ovarian insufficiency.循证指南：卵巢早衰
Climacteric. 2024 Dec;27(6):510-520. doi: 10.1080/13697137.2024.2423213. Epub 2024 Dec 8.
6
Breast Cancer Is Increased in Women With Primary Ovarian Insufficiency.原发性卵巢功能不全的女性患乳腺癌的风险增加。
J Clin Endocrinol Metab. 2025 Apr 22;110(5):e1678-e1686. doi: 10.1210/clinem/dgae480.
7
Management of unscheduled bleeding on HRT: A joint guideline on behalf of the British Menopause Society, Royal College Obstetricians and Gynaecologists, British Gynaecological Cancer Society, British Society for Gynaecological Endoscopy, Faculty of Sexual and Reproductive Health, Royal College of General Practitioners and Getting it Right First Time.HRT 非计划性出血管理：英国绝经学会、皇家妇产科医师学院、英国妇科癌症学会、英国妇科内镜学会、皇家全科医师学院性与生殖健康学院以及首次正确处理的联合指南。
Post Reprod Health. 2024 Jun;30(2):95-116. doi: 10.1177/20533691241254413. Epub 2024 May 14.
8
Progesterone from ovulatory menstrual cycles is an important cause of breast cancer.排卵月经周期中的孕激素是乳腺癌的一个重要病因。
Breast Cancer Res. 2023 May 30;25(1):60. doi: 10.1186/s13058-023-01661-0.
9
Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.激素替代疗法的使用与乳腺癌风险：使用 QResearch 和 CPRD 数据库的巢式病例对照研究。
BMJ. 2020 Oct 28;371:m3873. doi: 10.1136/bmj.m3873.
10
Hormone replacement therapy and the risk of endometrial cancer: A systematic review.激素替代疗法与子宫内膜癌风险：一项系统评价。
Maturitas. 2016 Sep;91:25-35. doi: 10.1016/j.maturitas.2016.05.013. Epub 2016 Jun 1.
Zotero 插件